about
Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor.Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor.High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell culturesActivation of autophagy in mesenchymal stem cells provides tumor stromal supportThe combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites.Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression.Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment.Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.Extracellular Vesicles: Evolving Factors in Stem Cell Biology.Inducible nitric oxide synthase modulates lipolysis in adipocytes.Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice.Isolation and expansion of mesenchymal stem cells/multipotential stromal cells from human bone marrow.Colony Forming Unit Assays.SV40 large T antigen immortalization of human articular chondrocytes
P50
Q33273792-859A1E57-FD74-4EA5-9D8E-54F06ECC77F3Q34634142-63D473D6-CFE6-4263-A959-E0B8FDBE06F9Q35000400-CAB99515-2901-4374-8469-5304CEC880C1Q35083520-FAD6A9DB-B00C-45E3-8923-5225D4A9360BQ35653799-6EE1AA3D-FF80-406A-BF38-438C45348E8BQ35741584-82A833AB-70F9-4425-91AC-9C1E0BD7BAFBQ36333354-99BFA37B-3C75-4848-9821-C657BE2B5C06Q36807630-6A4DC8B7-CF70-4009-88F2-81FE632826B4Q36985192-4E6AB009-CB2D-4481-A6E2-66BAFF85362FQ37090949-D7D8C157-4848-40B6-8002-AAAF22D2D9B9Q37090959-312B50B0-BF26-48CF-8DC2-2803F952945BQ38307717-36E62D86-CADA-402A-A6AD-8692DF0A2160Q38595997-9FD7532C-892F-4DC3-935F-6C59B7064D2DQ38663473-5E378966-D811-4328-BDD2-B35344A10250Q40507879-586F5082-7298-4E8E-8F9F-47272EF2CFCFQ43583255-92ECAE41-7DA0-4B0B-9D49-0B0C7497E322Q45868663-E2263E16-FB0B-49EA-ABC1-FC1355E58B48Q53092687-72A062BB-70DC-4012-8D2A-EC4F612D57F5Q72254153-D081FB14-160B-4B5E-84C0-6787B8F75EAF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patrice Penfornis
@ast
Patrice Penfornis
@en
Patrice Penfornis
@es
Patrice Penfornis
@sl
type
label
Patrice Penfornis
@ast
Patrice Penfornis
@en
Patrice Penfornis
@es
Patrice Penfornis
@sl
prefLabel
Patrice Penfornis
@ast
Patrice Penfornis
@en
Patrice Penfornis
@es
Patrice Penfornis
@sl
P1053
J-2545-2016
P106
P1153
6507900219
P21
P31
P3829
P496
0000-0001-7703-0070
P569
2000-01-01T00:00:00Z